The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.
about
Truncated somatostatin receptor variant sst5TMD4 confers aggressive features (proliferation, invasion and reduced octreotide response) to somatotropinomasIn1-ghrelin, a splice variant of ghrelin gene, is associated with the evolution and aggressiveness of human neuroendocrine tumors: Evidence from clinical, cellular and molecular parametersPresence of sst5TMD4, a truncated splice variant of the somatostatin receptor subtype 5, is associated to features of increased aggressiveness in pancreatic neuroendocrine tumors.BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomas.The truncated somatostatin receptor sst5TMD4 stimulates the angiogenic process and is associated to lymphatic metastasis and disease-free survival in breast cancer patients.Treatment of acromegaly in the era of personalized and predictive medicine.Management of aggressive growth hormone secreting pituitary adenomas.Theoretical analysis of somatostatin receptor 5 with antagonists and agonists for the treatment of neuroendocrine tumors.Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis.International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
P2860
Q35228970-470EE4A4-873E-4D0D-84DF-205A0C1A580CQ36260604-A596FDBB-CF13-4BB9-A11D-082B16F3AEAFQ36916282-65D06F0E-8D25-4504-A09A-AF57053339AEQ37633385-D5C74022-D558-45AA-B4FF-3C976EACF757Q37644995-9610FF46-AE15-4EEB-96D1-A37FDBD3D15CQ38340014-BC915EF7-4D25-4F9C-9658-ED844D4F3FE4Q38781620-663F39C9-1902-42FF-8E36-CC6E41A646FBQ51019609-539263C3-EEEC-4B85-A5A8-841FC22F2811Q51563028-F9B35FD7-F97B-4734-94CF-BB60EA4CEC88Q57144951-82F92C17-1FFB-4F8C-9F5C-194F7A8CDD8C
P2860
The truncated isoform of somatostatin receptor5 (sst5TMD4) is associated with poorly differentiated thyroid cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 January 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The truncated isoform of somat ...... differentiated thyroid cancer.
@en
The truncated isoform of somatostatin receptor5
@nl
type
label
The truncated isoform of somat ...... differentiated thyroid cancer.
@en
The truncated isoform of somatostatin receptor5
@nl
prefLabel
The truncated isoform of somat ...... differentiated thyroid cancer.
@en
The truncated isoform of somatostatin receptor5
@nl
P2093
P2860
P50
P1433
P1476
The truncated isoform of somat ...... differentiated thyroid cancer.
@en
P2093
Antonio Alastrué
Francisco Lomeña
Gonzalo Díaz-Soto
Irene Halperin
Jordi L Reverter
José Luis Mate
Laureano Fernández-Cruz
Mattia Squarcia
Oscar Vidal
P2860
P304
P356
10.1371/JOURNAL.PONE.0085527
P407
P50
P577
2014-01-21T00:00:00Z